Edition:
United Kingdom

Dynavax Technologies Corp (DVAX.OQ)

DVAX.OQ on NASDAQ Stock Exchange Capital Market

7.10USD
22 Mar 2019
Change (% chg)

$-0.46 (-6.08%)
Prev Close
$7.56
Open
$7.51
Day's High
$7.52
Day's Low
$7.09
Volume
393,314
Avg. Vol
291,629
52-wk High
$22.75
52-wk Low
$7.09

Chart for

About

Dynavax Technologies Corporation is a clinical-stage immunotherapy company. The Company is focused on leveraging the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of... (more)

Overall

Beta: 1.45
Market Cap(Mil.): $1,380.17
Shares Outstanding(Mil.): 59.75
Dividend: --
Yield (%): --

Financials

  DVAX.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -2.48 -- --
ROI: -72.82 8.89 13.82
ROE: -73.07 10.02 15.24

Earnings vs. Estimates